期刊簡介 | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱![]() | eLife LetPub Score 8.4
51 ratings
Rate
Reputation 8.6 Influence 7.9 Speed 9.0 | ||||||||||||||||||||||||
期刊簡稱 | ELIFE | ||||||||||||||||||||||||
ISSN | 2050-084X | ||||||||||||||||||||||||
h-index | 93 | ||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||
自引率 (2023-2024) | 1.60%自引率趨勢 | ||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||
官方網站 | https://elifesciences.org/ | ||||||||||||||||||||||||
在線稿件提交 | https://reviewer.elifesciences.org/login | ||||||||||||||||||||||||
開放訪問 | Yes | ||||||||||||||||||||||||
出版商 | eLife Sciences Publications | ||||||||||||||||||||||||
主題領域 | BIOLOGY | ||||||||||||||||||||||||
出版國/地區 | ENGLAND | ||||||||||||||||||||||||
發行頻率 | |||||||||||||||||||||||||
創刊年 | 0 | ||||||||||||||||||||||||
每年文章數 | 1332每年文章數趨勢 | ||||||||||||||||||||||||
黃金OA百分比 | 99.60% | ||||||||||||||||||||||||
OA Related Info![]() | APC: Yes( USD3000; ) APC waiver:Check Notes Other charges: No Keywords: biomedicine、life sciences Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | ||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2050-084X%5BISSN%5D | ||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: 17 Weeks | ||||||||||||||||||||||||
競爭力 * | 來自作者的數據: | ||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
|
首頁 上一頁 1 2 3 4 5 6 7 下一頁 末頁 (頁 | |
[eLife] 的評論 | 撰寫評論 |
作者: 牛哥919 領域: 生物学 審稿時間: 12.0 month(s) 結果: 修改後接受 撰寫評論 |
2025-03-25 11:24:10 評論於 1: ESCI 2: No impact factor for 25 years, can't say about the zone of 26 3: If your paper has high completeness, it will be included, with a 97% inclusion rate 4: Payment is only required after submission for review, rejection means it was not submitted, and no payment is needed ![]() ![]() |
作者: 李炼师 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2025-03-21 15:44:48 評論於 Could you please tell me the current situation of Elfie (the zone announced by the Chinese Academy of Sciences at the end of March 2025)? Specifically, include the following: 1. Is it SCIE or ESCI? I want to submit an article but I'm afraid of wasting it. 2. Since there is no impact factor, how is the zone calculated by the Chinese Academy of Sciences? (From the above, it seems to still be in the first zone.) 3. It is also a concern that some articles are included (if my article is not included, even if it is in the first zone, it is not a scientific achievement). 4. I heard that you have to pay first and then get the result. If you pay and then get rejected, wouldn't that be very unfortunate? ![]() ![]() |
作者: Lvpori 領域: 生物学 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2025-01-31 00:40:31 評論於 eLife has always been a journal that I really like, and I published an article here last year. Although it was embroiled in a public relations crisis at the end of last year, it cannot be denied that its open peer review and innovative publishing model still hold significant value for the academic community. The reason I am writing this comment today is because I have received another email from the new editor-in-chief, Dr. Tim Behrens, encouraging authors to continue submitting their work. In any case, eLife will still be one of the journals I consider for publication in the future. ![]() ![]() |
作者: DrJhaha 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-12-02 17:25:45 評論於 When the tide goes out, you can see who's been swimming naked. ![]() ![]() |
作者: hengheng12 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-11-06 16:10:09 評論於 There is a high probability that a journal put on hold will be removed from SCI, and the chance of being reinstated is very small. ![]() ![]() |
作者: 留云一南 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-10-29 21:03:16 評論於 Latest news, the top journal in the first district of Chinese Academy of Sciences, the renowned life science journal eLife (IF 6.4), has been officially put "On hold" by Clarivate Analytics! ![]() ![]() |
作者: 翻滚吧牛便便 領域: 医学 審稿時間: 2.0 month(s) 結果: 拒稿 撰寫評論 |
2024-10-28 21:36:44 評論於 Submit for review - pay layout fee - pre-print - external review, everything goes smoothly. Suddenly on hold on the 24th, received an email on the 28th saying they couldn't find enough reviewers and rejected my submission! Please help, what should I do with the article, what about the layout fee?! ![]() ![]() |
作者: sci助理 領域: 医学 審稿時間: 7.0 month(s) 結果: 直接被接受 撰寫評論 |
2024-10-25 16:19:20 評論於 It's on hold, really frustrating, all the good journals have been taken. ![]() ![]() |
作者: Vincent H. 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-10-25 10:00:52 評論於 How about flipping the table, abandoning Clarivate Analytics, and choosing another database? For example, Scopus. ![]() ![]() |
作者: 向往有你一方 領域: 环境科学与生态学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-10-25 03:18:03 評論於 Clarivate Analytics, alas, let's not play anymore. ![]() ![]() |
作者: ID518 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-10-24 22:52:23 評論於 Web of Science ![]() ![]() |
作者: xxx636 領域: 农林科学 審稿時間: 12.0 month(s) 結果: 直接被接受 撰寫評論 |
2024-10-24 21:51:17 評論於 Just passing by, the eLife being on hold can be understandable, what does it mean for Science Citation Index? Is Clarivate a bit off track? ![]() ![]() |
作者: lxy 領域: 工程技术 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-10-24 21:19:34 評論於 Where did you check the status of the journal? ![]() ![]() |
作者: ID518 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-10-24 20:27:48 評論於 Just found out that Elife is on hold until 2024-10-24. Does anyone know what's going on? Is it a new review process? ![]() ![]() |
作者: 是志丹吖 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-10-24 12:41:16 評論於 Breaking news, the top journal in the Chinese Academy of Sciences Area 1, the renowned life science journal eLife (IF 6.4), has been officially put "On hold" by Clarivate Analytics! ![]() ![]() |
作者: 震雷博超 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-10-23 18:03:03 評論於 Research focus: cancer biology Experience sharing: eLife is on hold, could it be related to its peer review process? ![]() ![]() |
作者: 黑山珠佩 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-10-17 23:29:31 評論於 Yes. ![]() ![]() |
作者: 风满元枫 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-09-25 21:46:16 評論於 How is your article doing now under editorial assessment? How long has it been? ![]() ![]() |
作者: 冰鸟爱 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-09-25 15:00:00 評論於 The same results as yours, the editor decided to write that the work is very interesting, but the current results are preliminary, and I need to supplement long-term follow-up results and increase testing items. ![]() ![]() |
作者: 雁翠小哥哥 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-09-22 19:48:43 評論於 Same question. ![]() ![]() |
作者: KAIXINTIEQUAN 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-09-21 11:07:25 評論於 What does "Review process complete" mean after "Under editorial assessment"? Does it mean the submission has been rejected? The email said it has been considered by the editor, but priority will be given to submissions that can generate high-quality public reviews that are of significant value to the community. ![]() ![]() |
作者: KAIXINTIEQUAN 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-09-21 10:58:58 評論於 How should the reply to the submission email and the journal status be written? ![]() ![]() |
作者: 幽香绿荷 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-09-20 14:38:03 評論於 35 days ![]() ![]() |
作者: 幽香绿荷 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-09-20 13:01:53 評論於 What does the rejection reply look like? I don't understand the meaning of the email. He said it has been considered by the editors, but they will prioritize submissions that can generate high-quality public comments of significant value to the community. Is it a rejection? ![]() ![]() |
作者: Adelaide Lawson 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-09-18 22:53:16 評論於 It's not necessarily, the editor may be busy, so please be patient. ![]() ![]() |
首頁 上一頁 1 2 3 4 5 6 7 下一頁 末頁 (頁 |
Contact us